Factors predicting the response of patients with advanced breast cancer to endocrine (Megace) therapy
- 1 March 1989
- journal article
- research article
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 25 (3) , 469-475
- https://doi.org/10.1016/0277-5379(89)90259-9
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- The definition of the ‘no change’ category in patients treated with endocrine therapy and chemotherapy for advanced carcinoma of the breastEuropean Journal of Cancer and Clinical Oncology, 1988
- Oestrogen receptors in primary and advanced breast cancer: An eight year review of 704 casesBritish Journal of Cancer, 1987
- Phase II evaluation of megestrol acetate in previously treated patients with advanced breast cancer: Relationship of response to previous treatmentEuropean Journal of Cancer and Clinical Oncology, 1986
- Megestrol acetate therapy for advanced breast cancer.Journal of Clinical Oncology, 1985
- Treatment of advanced breast cancer with megestrol acetate after therapy with tamoxifenCancer, 1982
- Steroid receptors in early breast cancer: Value in prognosisJournal of Steroid Biochemistry, 1981
- Progestin therapy in advanced breast cancer: Megestrol acetate—an evaluation of 160 treated casesCancer, 1980
- Assessment of response to therapy in advanced breast cancer.A project of the programme on clinical oncology of the International Union against Cancer, Geneva, SwitzerlandCancer, 1977